Article: Automating decentralized manufacturing of cell & gene therapy products

Richard P Harrison, Qasim A Rafiq & Nicholas Medcalf on why decentralised, or redistributed manufacture, is likely to be the manufacturing approach of choice for some cell- and gene-based therapies, in particular, personalised therapies. Read the full article on the BioInsights website.

Facebooktwittergoogle_plusredditpinterestlinkedinmail